Skip to main content
Erschienen in: Annals of Nuclear Medicine 1/2017

04.11.2016 | Original Article

Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye

verfasst von: Federica Elisei, Cinzia Crivellaro, Daniela Giuliani, Carlotta Dolci, Elena De Ponti, Luca Montanelli, Maria La Manna, Luca Guerra, Maurizio Arosio, Claudio Landoni, Alessandro Buda

Erschienen in: Annals of Nuclear Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to compare preoperative SPECT/CT with gamma-probe and methylene blue-dye (MBD) in the identification of sentinel lymph node (SLN) in early stage endometrial cancer.

Methods

40 stage-I EC patients (66.7 ± 9.7 years) underwent preoperative lymphoscintigraphy. After about 3 h from Tc-99m-albumin nanocolloid cervical injection, all patients underwent SPECT/CT study. MBD was injected into the cervix just before surgery under general anesthesia. All patients underwent SLN biopsy, hysterectomy, bilateral salpingo-oophorectomy, and radical regional lymphadenectomy. SPECT/CT findings were compared to those of gamma-probe and MBD techniques.

Results

In 2 patients no nodal migration was observed, neither with MBD nor radiotracer. Detection rate of at least one SLN was 90% (36/40 patients) with SPECT/CT, 88% (35/40) intra-operatively with gamma-probe and 80% (32/40) with MBD. Only in 7/40 patients a bilateral migration was obtained with all considered modalities. In particular, bilateral detection was achieved in 26 patients with SPECT/CT, in 24 with gamma-probe and in 10 patients with MBD. The concordance site between SPECT/CT and intraoperative gamma-probe was 73% (29/40 patients: 2 without migration, 21 bilateral and 6 monolateral SLNs); while concordance site with MBD was found in 40% (16/40: 8 bilateral, 6 monolateral SLNs, 2 without SLNs). Overall, 628 LNs were dissected (mean 18 LNs per patient). The median number of SLNs removed was 2 (mean 2.5 per patient). Out of 91 SLNs: 43 were “hot and blue (HB)”, 10 were blue only and 38 were hot only. LN metastases rate was 16%: 9/90 SLNs (7 HB, 2 hot only) were positive for metastases in 6 patients. Four non-SLNs were found positive in 3 patients, and all presented concomitant positive SLNs. False negative rate was 0%.

Conclusions

SPECT/CT had the highest detection rate and achieved the highest rate of bilateral mapping, compared to gamma-probe and MDB. SPECT/CT had moderate concordance with gamma-probe, and it can help the intraoperative detection of SLNs providing important information about their anatomic location.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed
2.
Zurück zum Zitat Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRefPubMed Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRefPubMed
3.
Zurück zum Zitat Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.CrossRefPubMed Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.CrossRefPubMed
4.
Zurück zum Zitat Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi33–8.CrossRefPubMed Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi33–8.CrossRefPubMed
5.
Zurück zum Zitat May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010;(1):CD007585. doi:10.1002/14651858. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010;(1):CD007585. doi:10.​1002/​14651858.
6.
Zurück zum Zitat Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, et al. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol. 2013;130:306–11.CrossRefPubMed Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, et al. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol. 2013;130:306–11.CrossRefPubMed
7.
Zurück zum Zitat Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up dagger. Ann Oncol. 2016;27:16–41.CrossRefPubMed Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up dagger. Ann Oncol. 2016;27:16–41.CrossRefPubMed
9.
Zurück zum Zitat Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2013;20:353–4.CrossRefPubMed Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2013;20:353–4.CrossRefPubMed
10.
Zurück zum Zitat Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw. 2014;12:288–97.PubMed Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw. 2014;12:288–97.PubMed
11.
Zurück zum Zitat Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, et al. Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study. Ann Nucl Med. 2015;29:63–70.CrossRefPubMed Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, et al. Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study. Ann Nucl Med. 2015;29:63–70.CrossRefPubMed
12.
Zurück zum Zitat Yoneyama H, Tsushima H, Onoguchi M, Konishi T, Nakajima K, Matsuo S, et al. Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems. Ann Nucl Med. 2015;29:248–55.CrossRefPubMed Yoneyama H, Tsushima H, Onoguchi M, Konishi T, Nakajima K, Matsuo S, et al. Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems. Ann Nucl Med. 2015;29:248–55.CrossRefPubMed
13.
Zurück zum Zitat Jewell EL, Huang JJ, Abu-Rustum NR, Gardner GJ, Brown CL, Sonoda Y, et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol. 2014;133:274–7.CrossRefPubMed Jewell EL, Huang JJ, Abu-Rustum NR, Gardner GJ, Brown CL, Sonoda Y, et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol. 2014;133:274–7.CrossRefPubMed
14.
Zurück zum Zitat Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer Tc and/or blue dye. Ann Surg Oncol. 2016;23:2183–91.CrossRefPubMed Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer Tc and/or blue dye. Ann Surg Oncol. 2016;23:2183–91.CrossRefPubMed
15.
Zurück zum Zitat Buda A, Elisei F, Arosio M, Dolci C, Signorelli M, Perego P, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer. 2012;22:830–5.CrossRefPubMed Buda A, Elisei F, Arosio M, Dolci C, Signorelli M, Perego P, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer. 2012;22:830–5.CrossRefPubMed
16.
Zurück zum Zitat Reiffenstuhl G. Contribution on the nomenclature of the pelvic lymph nodes. Wien Klin Wochenschr. 1956;68:247–8.PubMed Reiffenstuhl G. Contribution on the nomenclature of the pelvic lymph nodes. Wien Klin Wochenschr. 1956;68:247–8.PubMed
17.
Zurück zum Zitat St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, et al. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol. 2016;23:1653–9.CrossRefPubMed St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, et al. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol. 2016;23:1653–9.CrossRefPubMed
18.
Zurück zum Zitat Ferraioli D, Chopin N, Beurrier F, Carrabin N, Buenerd A, Mathevet P. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer. Int J Gynecol Cancer. 2015;25:673–80.CrossRefPubMed Ferraioli D, Chopin N, Beurrier F, Carrabin N, Buenerd A, Mathevet P. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer. Int J Gynecol Cancer. 2015;25:673–80.CrossRefPubMed
19.
Zurück zum Zitat Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123:522–7.CrossRefPubMed Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol. 2011;123:522–7.CrossRefPubMed
20.
Zurück zum Zitat Perissinotti A, Paredes P, Vidal-Sicart S, Torne A, Albela S, Navales I, et al. Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer. Gynecol Oncol. 2013;129:42–8.CrossRefPubMed Perissinotti A, Paredes P, Vidal-Sicart S, Torne A, Albela S, Navales I, et al. Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer. Gynecol Oncol. 2013;129:42–8.CrossRefPubMed
21.
Zurück zum Zitat Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.CrossRefPubMed Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.CrossRefPubMed
22.
Zurück zum Zitat Sawicki S, Kobierski J, Lapinska-Szumczyk S, Lass P, Cytawa W, Bianek-Bodzak A, et al. Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer. Nucl Med Commun. 2013;34:590–6.CrossRefPubMed Sawicki S, Kobierski J, Lapinska-Szumczyk S, Lass P, Cytawa W, Bianek-Bodzak A, et al. Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer. Nucl Med Commun. 2013;34:590–6.CrossRefPubMed
23.
Zurück zum Zitat Ballester M, Rouzier R, Coutant C, Kerrou K, Darai E. Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol Oncol. 2009;112:348–52.CrossRefPubMed Ballester M, Rouzier R, Coutant C, Kerrou K, Darai E. Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol Oncol. 2009;112:348–52.CrossRefPubMed
24.
Zurück zum Zitat Brucker SY, Taran FA, Wallwiener D. Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine? Arch Gynecol Obstet. 2014;290:9–11.CrossRefPubMed Brucker SY, Taran FA, Wallwiener D. Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine? Arch Gynecol Obstet. 2014;290:9–11.CrossRefPubMed
25.
Zurück zum Zitat Buda A, Elisei F, Palazzi S, De Ponti E, Arosio M, Vecchione F, et al. Quality of care for cervical and endometrial cancer patients: the impact of different techniques of sentinel lymph node mapping on patient satisfaction. Ann Surg Oncol. 2016;23:2975–81.CrossRefPubMed Buda A, Elisei F, Palazzi S, De Ponti E, Arosio M, Vecchione F, et al. Quality of care for cervical and endometrial cancer patients: the impact of different techniques of sentinel lymph node mapping on patient satisfaction. Ann Surg Oncol. 2016;23:2975–81.CrossRefPubMed
26.
Zurück zum Zitat Touboul C, Bentivegna E, Uzan C, Gouy S, Pautier P, Lhomme C, et al. Sentinel lymph node in endometrial cancer: a review. Curr Oncol Rep. 2013;15:559–65.CrossRefPubMed Touboul C, Bentivegna E, Uzan C, Gouy S, Pautier P, Lhomme C, et al. Sentinel lymph node in endometrial cancer: a review. Curr Oncol Rep. 2013;15:559–65.CrossRefPubMed
27.
Zurück zum Zitat Cibula D, Oonk MH, Abu-Rustum NR. Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol. 2015;27:66–72.CrossRefPubMed Cibula D, Oonk MH, Abu-Rustum NR. Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol. 2015;27:66–72.CrossRefPubMed
28.
Zurück zum Zitat Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol. 2010;117:59–64.CrossRefPubMed Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol. 2010;117:59–64.CrossRefPubMed
29.
Zurück zum Zitat Darin MC, Gomez-Hidalgo NR, Westin SN, Soliman PT, Escobar PF, Frumovitz M, et al. Role of indocyanine green in sentinel node mapping in gynecologic cancer: is fluorescence imaging the new standard? J Minim Invasive Gynecol. 2016;23:186–93.CrossRefPubMed Darin MC, Gomez-Hidalgo NR, Westin SN, Soliman PT, Escobar PF, Frumovitz M, et al. Role of indocyanine green in sentinel node mapping in gynecologic cancer: is fluorescence imaging the new standard? J Minim Invasive Gynecol. 2016;23:186–93.CrossRefPubMed
30.
Zurück zum Zitat Buda A, Papadia A, Zapardiel I, Vizza E, Ghezzi F, De Ponti E, et al. From conventional radiotracer Tc-99 with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol. 2016;23:2959–65.CrossRefPubMed Buda A, Papadia A, Zapardiel I, Vizza E, Ghezzi F, De Ponti E, et al. From conventional radiotracer Tc-99 with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol. 2016;23:2959–65.CrossRefPubMed
31.
Zurück zum Zitat Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S, et al. Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2016;23:2206–11.CrossRefPubMedPubMedCentral Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S, et al. Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2016;23:2206–11.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat How J, Gotlieb WH, Press JZ, Abitbol J, Pelmus M, Ferenczy A, et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecol Oncol. 2015;137:436–42.CrossRefPubMed How J, Gotlieb WH, Press JZ, Abitbol J, Pelmus M, Ferenczy A, et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecol Oncol. 2015;137:436–42.CrossRefPubMed
33.
Zurück zum Zitat Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, et al. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes-a meta-analysis. Ann Surg Oncol. 2016;23:3749–56.CrossRefPubMed Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, et al. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes-a meta-analysis. Ann Surg Oncol. 2016;23:3749–56.CrossRefPubMed
34.
Zurück zum Zitat Devaja O, Nagar HA. Sentinel lymph node biopsy in endometrial cancer, scientific impact paper No. 51. 2016. Devaja O, Nagar HA. Sentinel lymph node biopsy in endometrial cancer, scientific impact paper No. 51. 2016.
35.
Zurück zum Zitat Montgomery LL, Thorne AC, Van Zee KJ, Fey J, Heerdt AS, Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385–8 (table of contents).PubMed Montgomery LL, Thorne AC, Van Zee KJ, Fey J, Heerdt AS, Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385–8 (table of contents).PubMed
36.
Zurück zum Zitat Salvatori M, Treglia G, Mores N. Further considerations on adverse reactions to radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2012;39:1360–2.CrossRefPubMed Salvatori M, Treglia G, Mores N. Further considerations on adverse reactions to radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2012;39:1360–2.CrossRefPubMed
37.
Zurück zum Zitat Holloway RW, Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, et al. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging. Gynecol Oncol. 2012;126:25–9.CrossRefPubMed Holloway RW, Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, et al. Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging. Gynecol Oncol. 2012;126:25–9.CrossRefPubMed
Metadaten
Titel
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye
verfasst von
Federica Elisei
Cinzia Crivellaro
Daniela Giuliani
Carlotta Dolci
Elena De Ponti
Luca Montanelli
Maria La Manna
Luca Guerra
Maurizio Arosio
Claudio Landoni
Alessandro Buda
Publikationsdatum
04.11.2016
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 1/2017
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-016-1137-0

Weitere Artikel der Ausgabe 1/2017

Annals of Nuclear Medicine 1/2017 Zur Ausgabe